Calidi Biotherapeutics Inc (CLDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,004 | -10,823 | -5,062 | -22,209 | -18,061 |
| Depreciation Amortization | 1,228 | 801 | 394 | 1,580 | 1,183 |
| Accounts payable and accrued liabilities | -924 | -733 | -752 | -628 | 537 |
| Other Working Capital | -3,215 | -3,102 | -3,035 | -1,698 | 552 |
| Other Operating Activity | 2,666 | 1,846 | 1,324 | 3,261 | 1,518 |
| Operating Cash Flow | $-16,249 | $-12,011 | $-7,131 | $-19,694 | $-14,271 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -91 | -64 | -7 | -16 | -11 |
| Investing Cash Flow | $-91 | $-64 | $-7 | $-16 | $-11 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 0 | 3,800 | 3,800 |
| Debt Repayment | -2,263 | -1,659 | -1,267 | -1,582 | -1,863 |
| Common Stock Issued | 20,307 | 10,079 | 10,076 | 25,010 | 11,383 |
| Other Financing Activity | -925 | -781 | -701 | 137 | 939 |
| Financing Cash Flow | $17,119 | $7,639 | $8,108 | $27,365 | $14,259 |
| Exchange Rate Effect | 6 | 6 | N/A | -13 | -29 |
| Beginning Cash Position | 9,809 | 9,809 | 9,809 | 2,167 | 2,167 |
| End Cash Position | 10,594 | 5,379 | 10,779 | 9,809 | 2,115 |
| Net Cash Flow | $785 | $-4,430 | $970 | $7,642 | $-52 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,249 | -12,011 | -7,131 | -19,694 | -14,271 |
| Capital Expenditure | -91 | -64 | -7 | -16 | -11 |
| Free Cash Flow | -16,340 | -12,075 | -7,138 | -19,710 | -14,282 |